EUCTR2018-002267-25-CZ进行中（未招募）1 期
SAFETY AND EFFICACY OF OLANZAPINE TREATMENT IN PSYCHOSIS: EFFECT OF GENETIC AND EPIGENETIC FACTORS – COVARIATES OF TREATMENT RESPONSE - SEOTP
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Dg. F20, F25 according to ICD-10 , treated with olanzapine or initiated treatment by olanzapine
- •2. Age 18-60 years
- •3. Signing the informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Involuntary hospitalization
- •2. Sui juris restriction or divestiture
- •3. Olanzapine or caffeine contraindication
- •4. Pregnancy or breastfeeding
- •5. Disagreement with the required contraception method(s)
- •6. Prior participation in any other trial involving investigational medication or medical devices within 14 days prior to the enrolment and during this trial;
- •7. Other serious medical or psychiatric illness that is not adequately controlled and, in the Investigator’s opinion, would not permit the subject to be managed according to the protocol.
研究者
相似试验
招募中
1 期
Safety and efficacy of olanzapine treatment in psychosis: Effect of genetic and epigenetic factors – covariates of treatment responsePsychosesMedDRA version: 20.0Level: PTClassification code: 10039626Term: Schizophrenia Class: 100000004873MedDRA version: 21.1Level: LLTClassification code: 10039613Term: Schizo-affective type schizophrenia Class: 10037175CTIS2022-502902-33-00Masarykova Univerzita200
尚未招募
4 期
To compare the effectivity and safety of Olanzapine and Mirtazapine on cancer associated anorexia and cachexia in advanced oral cavity cancer patientsCTRI/2023/09/057995nil
已完成
不适用
Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder-F60F60PER-005-04ELI LILLY INTERAMERICA INC.,
尚未招募
3 期
Olanzapine in pediatric chemotherapy induced nausea and vomiting iIRCT20120415009475N14Vice Chancellor for research of Shahid Beheshti University of Medical Sciences56
已完成
3 期
A clinical trial to study the effect of olanzapine in patients receiving highly emetogenic chemotherapyCTRI/2019/01/017317All India Institute of Medical Sciences128